Vascular calcification and QT interval in incident hemodialysis patients

Area of Science:

• Nephrology
• Cardiology
• Clinical Pharmacology

Background:

• Cardiovascular calcification and QT dispersion are significant risks in hemodialysis patients.
• Phosphate binders are crucial for managing hyperphosphatemia in this population.
• Current evidence comparing different phosphate binders' long-term cardiovascular impact is limited.

Purpose of the Study:

• To evaluate the impact of sevelamer versus calcium-based phosphate binders on slowing cardiovascular calcification.
• To assess the effect of these binders on QT dispersion in incident hemodialysis patients.
• To compare the 36-month incidence of cardiovascular calcification mortality between the two binder groups.

Main Methods:

• A randomized, multicenter, prospective, interventional study design.
• Inclusion of incident hemodialysis patients over 18 years old.
• Randomization of 360 patients into two cohorts: sevelamer (180) and calcium-binder phosphate (180).

Main Results:

• Primary endpoint: cardiovascular calcification mortality at 36 months.
• Secondary endpoint: changes in QT dispersion over 36 months.
• Analysis will compare outcomes between the sevelamer and calcium-binder phosphate groups.

Conclusions:

• The study aims to provide critical data on the comparative efficacy of sevelamer and calcium-based phosphate binders.
• Findings will inform clinical practice regarding the management of cardiovascular risk in hemodialysis patients.
• Long-term data on cardiovascular calcification and QT dispersion will be generated.